Medicine and Dentistry
Oncolytic Virus
100%
Protoparvovirus
85%
Malignant Neoplasm
28%
Clinical Trial
14%
Glioblastoma
14%
Virus Typing
14%
Neoplasm
14%
Tumor Cell
14%
Blood Brain Barrier
14%
H-1 Parvovirus
14%
Immune Response
14%
Adenoviridae
14%
Nanoparticle
14%
Virus
14%
Keyphrases
Oncolytic Virus
50%
Protoparvovirus
42%
Chimeric Virus
14%
Enhanced Anticancer Efficacy
14%
Scientific Expertise
14%
H-1PV
7%
Clinical Trials
7%
Tumor Cells
7%
Clinical Setting
7%
Tumor
7%
Treatment Combination
7%
Adenovirus
7%
Oncolysis
7%
Anticancer Properties
7%
Clinical Outcomes
7%
Combinational Therapy
7%
In Cancer
7%
Cancer Therapeutics
7%
Clinical Protocols
7%
Wild Type Virus
7%
Intrinsic Properties
7%
Blood-brain Barrier
7%
Further Development
7%
Antitumor Immune Response
7%
Cancer Patients
7%
Clinically Approved Drugs
7%
Parvovirus H-1
7%
Non-engineered
7%
Clinical Levels
7%
Immune Checkpoint Molecules
7%
Physiological Barriers
7%
Anticancer Strategy
7%
Clinical Expertise
7%
Nanoparticles
7%
Recurrent Glioblastoma multiforme
7%
Pharmacology, Toxicology and Pharmaceutical Science
Oncolytic Virus
100%
Protoparvovirus
85%
Neoplasm
28%
Malignant Neoplasm
28%
Nanoparticle
14%
Glioblastoma
14%
Adenoviridae
14%
Clinical Trial
14%
H-1 Parvovirus
14%
Blood-Brain Barrier
14%